Cardinal Health (CAH) Is Buying Strive Medical And AdaptHealth Diabetes Business

• Cardinal Health (NYSE:CAH) has agreed to acquire Strive Medical, a provider of urology and wound care supplies for patients at home.
• The company is also buying AdaptHealth’s diabetes business, adding to its at-Home Solutions division.
• Both deals focus on expanding Cardinal Health’s home care offering in diabetes management and urology.
• The transactions are expected to be accretive to non-GAAP earnings within a year of closing.

Cardinal Health enters these transactions with its stock at $220.54, after a gain of 41.2% over the past year and a 5-year return of 312.2%. For investors tracking NYSE:CAH, the moves deepen the company’s reach in home-based care, an area that has been a growing focus within its at-Home Solutions division.

The Strive Medical and AdaptHealth diabetes acquisitions add scale and product depth in two core chronic care categories, diabetes and urology, that many investors view as structurally important in home health. With management expecting the deals to be accretive to non-GAAP earnings within a year, shareholders may watch closely how efficiently Cardinal Health integrates these assets and expands its at-home care footprint.

Stay updated on the most important news stories for Cardinal Health by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Cardinal Health.

📰 Beyond the headline: 2 risks and 2 things going right for Cardinal Health that every investor should see.

Quick Assessment

• ⚖️ Price vs Analyst Target: Cardinal Health trades at US$220.54 versus a consensus target of about US$250.73, roughly 12% below analyst expectations.
• ✅ Simply Wall St Valuation: The stock is described as trading about 55.3% below an estimated fair value.
• ❌ Recent Momentum: The share price has declined about 1% over the last 30 days.

There's only one way to know the right time to buy, sell or hold Cardinal Health. Head to Simply Wall St's company report for the latest analysis of Cardinal Health's Fair Value.

Key Considerations

• 📊 The Strive Medical and AdaptHealth diabetes deals extend Cardinal Health's at-Home Solutions reach in chronic care. This may support the existing investment case around scale and category depth.
• 📊 Watch how quickly management integrates these assets, any updates to earnings guidance, and whether the home-care segment mix affects Cardinal Health's P/E of 33.22 versus the industry average of 25.62.
• ⚠️ With two identified minor risks, including a high level of debt and one off items affecting results, investors may want to see that acquisition funding and integration do not worsen leverage or earnings quality.

Dig Deeper

For the full picture including more risks and rewards, check out the complete Cardinal Health analysis. Alternatively, you can check out the community page for Cardinal Health to see how other investors believe this latest news will impact the company's narrative.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com